Cargando…

Targeted exome sequencing identifies mutational landscape in a cohort of 1500 Chinese patients with non-small cell lung carcinoma (NSCLC)

BACKGROUND: Non-small cell lung carcinoma (NSCLC) is one of the most common human cancers, comprising approximately 80–85% of all lung carcinomas. An estimated incidence of NSCLC is approximately 2 million new cases per year worldwide. RESULTS: In recent decade, the treatment of NSCLC has made break...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ya-jun, Zheng, Wei, Zeng, Qing-hua, Ye, Yang, Wang, Ce, Fang, Cheng, Liu, Chao-jun, Niu, Li, Wu, Li-ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042687/ https://www.ncbi.nlm.nih.gov/pubmed/33845897 http://dx.doi.org/10.1186/s40246-021-00320-9

Ejemplares similares

Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing
por: Wang, Jie, et al.
Publicado: (2018)

Exome sequencing identifies novel and recurrent mutations in GJA8 and CRYGD associated with inherited cataract
por: Mackay, Donna S, et al.
Publicado: (2014)

Secondary findings in 421 whole exome-sequenced Chinese children
por: Chen, Wen, et al.
Publicado: (2018)

Pathogenic variants identified by whole-exome sequencing in 43 patients with epilepsy
por: Zhang, Linlin, et al.
Publicado: (2020)

Whole-exome sequencing identifies de novo mutation in the COL1A1 gene to underlie the severe osteogenesis imperfecta
por: Maasalu, Katre, et al.
Publicado: (2015)

Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients
por: Fichna, Jakub Piotr, et al.
Publicado: (2018)

Whole exome sequencing identifies novel candidate genes that modify chronic obstructive pulmonary disease susceptibility
por: Bruse, Shannon, et al.
Publicado: (2016)

Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera
por: Hirvonen, Elina A. M., et al.
Publicado: (2017)

Whole exome sequencing identifies common mutational landscape of cervix and endometrium small cell neuroendocrine carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Delineation of molecular findings by whole-exome sequencing for suspected cases of paediatric-onset mitochondrial diseases in the Southern Chinese population
por: Tsang, Mandy H.Y., et al.
Publicado: (2020)

Whole exome sequencing reveals novel somatic alterations in neuroblastoma patients with chemotherapy
por: Duan, Chao, et al.
Publicado: (2018)

Selecting short length nucleic acids localized in exosomes improves plasma EGFR mutation detection in NSCLC patients
por: Kim, Yoonjung, et al.
Publicado: (2019)

Detection of low-level parental somatic mosaicism for clinically relevant SNVs and indels identified in a large exome sequencing dataset
por: Domogala, Daniel D., et al.
Publicado: (2021)

LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p/eIF5A axis
por: Liu, Xiaojing, et al.
Publicado: (2021)

The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies
por: Patterson, Sara E., et al.
Publicado: (2016)

Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients
por: Cao, Xin-xin, et al.
Publicado: (2018)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Anticancer activity of Astragalus polysaccharide in human non-small cell lung cancer cells
por: Wu, Chao-Yan, et al.
Publicado: (2017)

Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder
por: Liu, Fatao, et al.
Publicado: (2021)

Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma
por: Wang, Xiaoyu, et al.
Publicado: (2015)

Exome sequencing identifies frequent mutation of MLL2 in non–small cell lung carcinoma from Chinese patients
por: Yin, Shanye, et al.
Publicado: (2014)

Antihelminthic benzimidazoles potentiate navitoclax (ABT-263) activity by inducing Noxa-dependent apoptosis in non-small cell lung cancer (NSCLC) cell lines
por: Lam, Lloyd T, et al.
Publicado: (2015)

Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis
por: Sun, Tingting, et al.
Publicado: (2021)

Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders
por: Fokstuen, S., et al.
Publicado: (2016)

Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing
por: Su, Shan, et al.
Publicado: (2019)

DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia
por: Lu, Quanyi, et al.
Publicado: (2013)

Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients
por: Liang, Yonghao, et al.
Publicado: (2022)

LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis
por: Zeng, Zhaolong, et al.
Publicado: (2020)

CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC)
por: Zhao, Yongsheng, et al.
Publicado: (2020)

Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway
por: Li, Mingzhu, et al.
Publicado: (2021)

EF24 exerts cytotoxicity against NSCLC via inducing ROS accumulation
por: Chang, Minghui, et al.
Publicado: (2021)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma
por: Chai, Rui-Chao, et al.
Publicado: (2019)

Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling
por: Zhou, Ji, et al.
Publicado: (2021)

Whole-Exome Sequencing Identifies Novel Somatic Mutations in Chinese Breast Cancer Patients
por: Zhang, Yanfeng, et al.
Publicado: (2015)

Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
por: Li, Kang, et al.
Publicado: (2022)

A pipeline combining multiple strategies for prioritizing heterozygous variants for the identification of candidate genes in exome datasets
por: Requena, Teresa, et al.
Publicado: (2017)

Whole exome sequencing identifies novel mutation in eight Chinese children with isolated tetralogy of Fallot
por: Liu, Lin, et al.
Publicado: (2017)

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer
por: Zhang, Manman, et al.
Publicado: (2020)

Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
por: Huang, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_40ofertm3gh9c4bnakvt6q12i5